ADVA Optical Networking Wins Prize for Best Energy Efficiency at SDN NFV World Congress
Oct 16, 2017 11:01 am UTC| Business
Network Transformation Awards Recognize ADVA FSP 3000 for Industry's Lowest Power Consumption The Hague, Netherlands. October 16, 2017. ADVA Optical Networking announced today that its FSP 3000 platform has won the...
Masergy Global UCaaS Solution Selected to Join GE Healthcare’s Centricity™ Partner Program
Oct 16, 2017 11:01 am UTC| Business
DALLAS, Oct. 16, 2017 -- Masergy, a leading provider of hybrid networking, managed security and cloud communications solutions, today announced that its Global Unified Communication as a Service (UCaaS) has been...
Oct 16, 2017 11:00 am UTC| Business
Limited treatment options are available today for diabetes-induced diastolic dysfunctionPLX cells showed cardio protective effects including reduced inflammation, decreased stiffness of cardiac muscles, and improved...
UTStarcom Reports Unaudited Financial Results for the First Half of 2017
Oct 16, 2017 11:00 am UTC| Business
HONG KONG, Oct. 16, 2017 -- UTStarcom (“UTStarcom” or “the Company”) (NASDAQ:UTSI), a global telecommunications infrastructure provider, today reported its unaudited financial results for the six months ended June 30,...
Oct 16, 2017 11:00 am UTC| Business
STAMFORD, Conn., Oct. 16, 2017 -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively...
Air Methods leader wins award for lifetime achievement
Oct 16, 2017 11:00 am UTC| Business
ENGLEWOOD, Colo., Oct. 16, 2017 -- If you’ve ever been life-flighted in a helicopter, driven by ambulance or wheeled down the hall in a hospital gurney, say a word of thanks to Air Methods’ Allen C. Wolfe Jr. for your...
Oct 16, 2017 11:00 am UTC| Business
PLYMOUTH MEETING, Pa., Oct. 16, 2017 -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced initiation of a phase 1b/2 immuno-oncology trial to evaluate Genentech/Roche’s atezolizumab (TECENTRIQ®) in combination...